Yuko Mori
3PUBLICATIONS
18CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (3)
Sort by Publication Date:
|Dec 31, 2024
Phase 3 Study of Talazoparib Plus Enzalutamide Versus Placebo Plus Enzalutamide as First-Line Treatment in Patients With Metastatic Castration-Resistant Prostate Cancer: TALAPRO-2 Japanese Subgroup Analysis.Nobuaki Matsubara, Hideaki Miyake, Hiroji Uemura
|Jul 30, 2022
Efficacy and safety of talazoparib in Japanese patients with germline BRCA-mutated locally advanced or metastatic breast cancer: results of the phase 1 dose-expansion study.Haruru Kotani, Norikazu Masuda, Toshinari Yamashita
|Jun 23, 2021
Safety, pharmacokinetics, and preliminary efficacy of the PARP inhibitor talazoparib in Japanese patients with advanced solid tumors: phase 1 study.Yoichi Naito, Yasutoshi Kuboki, Masafumi Ikeda
Pageof 1
Frequent Collaborators
3 joint publications
Shigeyuki Toyoizumi
3 joint publications
Natsuki Hori
2 joint publications
Yoichi Naito
2 joint publications
Nobuaki Matsubara
2 joint publications
Takashi Nagasawa
1 joint publications
Yasutoshi Kuboki
1 joint publications
Masafumi Ikeda
1 joint publications
Kenichi Harano
1 joint publications
Takahiro Kogawa
1 joint publications
Haruru Kotani
